Where to buy cimipilimab
Cemiplimab (Cemiplimab) is a drug that treats skin cancer by working with a patient’s immune system. Cimepilimab is primarily used to treat a type of skin cancer called cutaneous squamous cell carcinoma (CSCC) that has spread to other parts of the body or cannot be treated with radiation or surgery.
Cimepilimab is used to treat a type of skin cancer called basal cell carcinoma(BCC), which cannot be removed with surgery (locally advancedBCC) or has spread to other parts of the body (< span>MetastaticBCC), and the patient has receivedhedgehog pathway inhibitor (HHI) treatment, or is unable to receiveHHI treatment.

Cimepilimab is also used to treat a type of lung cancer called non-small cell lung cancer (NSCLC) as a first treatment when the cancer has not spread beyond the chest (locally advanced NSCLC) and surgery or radiation and chemotherapy are not possible, or when the cancer has spread to other parts of the body (metastatic NSCLC) and the tumor does not have abnormal "EGFR", "ALK" or "ROS1" genes. It is used in combination with platinum-containing chemotherapy or as a single agent when a patient's tumor also tests highly positive for PD-L1.
Cimepilimab causes the patient's immune system to attack normal organs and tissues anywhere in the body, affecting the way they work. These problems sometimes become serious or life-threatening and can lead to death. These problems can occur at any time during treatment or even after treatment has ended.
Cimepril monoclonal antibody has not yet entered the domestic market, and is not covered by the medical insurance system. As a result, its price information is unclear. Patients in need can only purchase this drug through overseas channels. Overseas, the drug is available in American and European versions, with a common specification of 350mg/7mL (50mg/mL). The price per box fluctuates between RMB 40,000 and RMB 100,000, depending on exchange rate fluctuations. It is worth mentioning that there are currently no generic cimipilimab drugs on the market.
Reference materials:https://www.drugs.com/libtayo.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)